Grand Pharmaceutical Group Limited (HKG:0512)
5.12
+0.09 (1.79%)
Mar 3, 2025, 4:08 PM HKT
HKG:0512 Revenue
Grand Pharmaceutical Group had revenue of 6.05B HKD in the half year ending June 30, 2024, with 16.01% growth. This brings the company's revenue in the last twelve months to 10.59B, up 2.40% year-over-year. In the year 2023, Grand Pharmaceutical Group had annual revenue of 10.53B with 10.12% growth.
Revenue (ttm)
10.59B
Revenue Growth
+2.40%
P/S Ratio
1.69
Revenue / Employee
982.58K
Employees
10,534
Market Cap
17.93B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 10.53B | 967.31M | 10.12% |
Dec 31, 2022 | 9.56B | 964.31M | 11.22% |
Dec 31, 2021 | 8.60B | 2.25B | 35.34% |
Dec 31, 2020 | 6.35B | -237.72M | -3.61% |
Dec 31, 2019 | 6.59B | 632.28M | 10.61% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
BeiGene | 29.60B |
JD Health International | 58.84B |
Hansoh Pharmaceutical Group Company | 13.00B |
WuXi Biologics | 18.39B |
Alibaba Health Information Technology | 31.39B |
Innovent Biologics | 8.01B |
Akeso | 2.01B |
Sinopharm Group | 634.32B |